ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Index funds generally provide more control over allocations than target date funds, which automate drift. This intro explains what that means in practice.
28,480 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
The BEA final read confirms economy grew 2.1% first quarter, signaling momentum. Here’s what drove growth and what ho...
Bitcoin holders are feeling the bite as higher gas bills and elevated mortgage costs reshape household budgets and cr...
Kroger’s stock move today sparked questions about earnings, margins, and future guidance. This analysis breaks down w...
Ethereum is showing real strength, rising sharply as momentum builds. In this guide, we break down the catalysts, ris...
February delivered a sharp 21.4% drop for BigBear.AI, widening concerns about AI stocks. This guide breaks down the d...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
A lighthearted moment on camera can ripple into budgets, brand deals, and privacy tradeoffs. Here’s how Shawn Johnson...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
As crypto markets swing, choosing the right project matters. This guide compares XRP and Cardano on technology, regul...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Alphabet and Meta Platforms sit at the center of digital advertising and AI bets. This analysis breaks down which cou...